TCR2 THERAPEUTICS
DEAD

Serial Number

97097081

Owner

TCR2 THERAPEUTICS INC.

Attorney

Brandon P. Leahy

Filing Date

Oct 28, 2021

Add to watchlist:

No watchlists yet
View on USPTO

TCR2 THERAPEUTICS Trademark

Serial Number: 97097081

TCR2 THERAPEUTICS is a trademark filed by TCR2 THERAPEUTICS INC. on October 28, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

TCR2 THERAPEUTICS INC. (5 trademarks)

100 BINNEY STREET, SUITE 710
CAMBRIDGE, MA 02142

Entity Type: 03

Trademark Details

Filing Date

October 28, 2021

Registration Date

Not Registered

Published for Opposition

September 13, 2022

Goods & Services

Pharmaceutical preparations, namely, therapeutic cells, therapeutic proteins and therapeutic nucleic acids for human use for the treatment and prevention of cancer, inflammation and inflammatory diseases; pharmaceutical preparations for human use, namely, biotherapeutics, medicines, and therapeutics, namely, pharmaceutical polypeptides, pharmaceutical antibodies, pharmaceutical nucleic acids, polypeptide-based therapeutics, cell-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics for the treatment and prevention of cancer, inflammation and inflammatory diseases

Scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics; providing information on the subject of scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 11, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 11, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 6, 2023 EXRA
SOU EXTENSION 1 GRANTED
Apr 4, 2023 EX1G
SOU EXTENSION 1 FILED
Apr 4, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 4, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 8, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 13, 2022 NPUB
PUBLISHED FOR OPPOSITION
Sep 13, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 24, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 10, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 10, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 10, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 10, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 10, 2022 CNEA
ASSIGNED TO EXAMINER
Aug 8, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 9, 2021 NWOS
NEW APPLICATION ENTERED
Nov 1, 2021 NWAP